BMEZ
BlackRock Health Sciences Trust II
NYSE: BMEZ · FINANCIAL SERVICES · ASSET MANAGEMENT
$14.01
+0.07% today
Updated 2026-04-29
Market cap
$880.64M
P/E ratio
5.55
P/S ratio
8.67x
EPS (TTM)
$2.54
Dividend yield
—
52W range
$13 – $15
Volume
0.2M
BlackRock Health Sciences Trust II (BMEZ) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$14.01
12-Month target
$14.00
2030 Target
—
Intrinsic (DCF)
—
Financial forecast
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 | 2027 (E) | 2028 (E) | 2029 (E) | 2030 (E) |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.0B | $0.1B | $-0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| EPS | — | — | — | — | — | — | — | — | — |
CAGR applied: -26.69% (capped 20%) · P/E: 5.55x (capped 25x) · Margin: 0.00%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.